Abstract
CD40 ligand (CD40L) delivers a contact-dcpendent signal to B cells which, in the presence of interleukin (IL)-4, drives immunoglobulin isotype switching to IgE. CD40L expression in T cells is transient, requires activation of protein kinase C and a rise in intracellular calcium concentration ([Ca2), and is inhibited by cyclosporin A (CsA). CsA also inhibited T-cell-dependent IL-4-driven IgE synthesis. We have found that expression of CD40L is developmentally regulated. Expression ofCD40L was restricted to mature single-positive thymocytes which, in the presence of IL-4, were capable of inducing B cells to undergo IgE isotype switching. CD40L expression was severely decreased in cord blood lymphocytes and was associated with a severely decreased ability to undergo T-celldependent IgE isotype switching. Caremark and from NMC Homecare. RF is the recipient of a Clinical Investigator Award from the NIAID, K08 AI-01091.
Original language | English (US) |
---|---|
Pages (from-to) | 43-44 |
Number of pages | 2 |
Journal | International archives of allergy and immunology |
Volume | 107 |
Issue number | 1-3 |
DOIs | |
State | Published - 1995 |
Funding
Keywords
- B cells
- CD40 ligand
- Cord blood
- Cyclosporin A
- IgE
- Immunoglobulin isotype switching
- Interleukin-4
- Newborn
- T cells
- Thymocytes
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology